Organization
Mimetogen Pharmaceuticals USA
2 clinical trials
Clinical trial
A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Clinical Study to Assess the Efficacy and Safety of 5% Tavilermide Ophthalmic Solution for the Treatment of Dry EyeStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Clinical trial
Multi-Center, Randomized,Double-Masked, Vehicle-Controlled Study to Assess the Safety and Efficacy Study of Tavilermide Ophthalmic Solutions for the Treatment of Dry EyeStatus: Completed, Estimated PCD: 2020-06-11